Home » Newsletters » BioWorld

BioWorld

Feb. 19, 1993

View Archived Issues

SBIR FOR DRUG TO TREAT BRAIN DEATH

APPOINTMENTS AND ADVANCEMENTS

MULTINATIONAL HEPATITIS B TRIALS

VICAL GETS PATENT ALLOWANCE

HEMOSOL READIES PUBLIC OFFERING

BIOINSECTICIDE APPROVED IN MEXICO

FACTOR VIII-C PATENT UPHELD

CAUTIOUS RESPONSE TO CLINTON'S PLAN

CAMBRIDGE BIOTECH SEEKS TO PULL REGISTRATION

GROWTH HORMONE DESIGNATED ORPHAN DRUG

CEL-SCI PACT FOR MANUFACTURING PLANT

IBA MEMBERS RATIFY MERGER WITH ABC

CARTILAGE, BONE TISSUE GROWN IN VITRO

APPLIED BIOSYSTEMS MERGER OFFICIAL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...